DeviceClearance

DIASORIN LIASON RUBELLA IGG ASSAY; DIASORIN LIAISON RUBELLA IGG TRI-CONTROLS— 510(k) K073390

Substantially Equivalent

DiaSorin, Inc.

FDA 510(k) clearance K073390 for DIASORIN LIASON RUBELLA IGG ASSAY; DIASORIN LIAISON RUBELLA IGG TRI-CONTROLS, Substantially Equivalent on 2008-11-21. Applicant: DiaSorin, Inc..

Clearance details

Applicant
DiaSorin, Inc.
Product code
Code LFX
Advisory panel
Microbiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Stillwater, MN, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.